Clinical trial
Once-Daily Drug Regimen for HIV-Infected Patients
NCT00001968 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001968 |
|---|---|
| Title | Once-Daily Drug Regimen for HIV-Infected Patients |
| Official title | A Pilot Study of Once-Daily Therapy With Amprenavir, Ritonavir, Lamivudine and Abacavir in HIV-Infected, Antiretroviral-Naive Patients |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acquired Immunodeficiency Syndrome, HIV Infections |
| Intervention type | Drug |
| Interventions | Amprenavir, Ritonavir, Abacavir, Lamivudine |
| Enrollment | 25 |
| Start date | Jan 1, 2000 |
| Completion | Nov 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: